Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Roher

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Neurobiology of Aging|January 1, 1994
Increased accumulation of cAMP in cerebral microvessels in Alzheimer's diseaseP Grammas, A E Roher, M J Ball
Dementia (Basel, Switzerland)|September 1, 1994
Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brainsA Stojanovic, A E Roher, M J Ball
Trends in Cardiovascular Medicine|January 20, 2011
Protein aging Extracellular amyloid formation and intracellular repairJ D Lowenson, A E Roher, S Clarke
The Journal of Cell Biology|December 1, 1988
Isolation and chemical characterization of Alzheimer's disease paired helical filament cytoskeletons: differentiation from amyloid plaque core proteinA E Roher, K C Palmer, V Chau, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's diseaseR O Weller, A Massey, Y M Kuo, et al.
Biochemical and Biophysical Research Communications|January 31, 1991
Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neuronsA E Roher, M J Ball, S V Bhave, et al.
Dementia (Basel, Switzerland)|May 1, 1995
Alzheimer disease amyloid proteins inhibit brain endothelial cell proliferation in vitroP Grammas, T Botchlet, R Fugate, et al.
Protein Engineering|October 31, 1998
Molecular modeling of the Abeta1-42 peptide from Alzheimer's diseaseM O Chaney, S D Webster, Y M Kuo, et al.
Neuroscience Letters|August 29, 2001
Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmineT G Beach, Y M Kuo, C Schwab, et al.
Biochimica Et Biophysica Acta|June 19, 1998
Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's diseaseY M Kuo, S Webster, M R Emmerling, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Neurobiology of Aging|January 1, 1994
Increased accumulation of cAMP in cerebral microvessels in Alzheimer's diseaseP Grammas, A E Roher, M J Ball
Dementia (Basel, Switzerland)|September 1, 1994
Quantitative analysis of lipofuscin and neurofibrillary tangles in the hippocampal neurons of Alzheimer disease brainsA Stojanovic, A E Roher, M J Ball
Trends in Cardiovascular Medicine|January 20, 2011
Protein aging Extracellular amyloid formation and intracellular repairJ D Lowenson, A E Roher, S Clarke
The Journal of Cell Biology|December 1, 1988
Isolation and chemical characterization of Alzheimer's disease paired helical filament cytoskeletons: differentiation from amyloid plaque core proteinA E Roher, K C Palmer, V Chau, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's diseaseR O Weller, A Massey, Y M Kuo, et al.
Biochemical and Biophysical Research Communications|January 31, 1991
Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neuronsA E Roher, M J Ball, S V Bhave, et al.
Dementia (Basel, Switzerland)|May 1, 1995
Alzheimer disease amyloid proteins inhibit brain endothelial cell proliferation in vitroP Grammas, T Botchlet, R Fugate, et al.
Protein Engineering|October 31, 1998
Molecular modeling of the Abeta1-42 peptide from Alzheimer's diseaseM O Chaney, S D Webster, Y M Kuo, et al.
Neuroscience Letters|August 29, 2001
Reduction of cortical amyloid beta levels in guinea pig brain after systemic administration of physostigmineT G Beach, Y M Kuo, C Schwab, et al.
Biochimica Et Biophysica Acta|June 19, 1998
Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A beta peptides of Alzheimer's diseaseY M Kuo, S Webster, M R Emmerling, et al.
Pageof 5